Finance expert Roger Stein brings a fresh, clever solution to the problem of funding drug development: Recast drugs as “financial assets,” and “let the research drive the funding.” This concept can save lives but needs broad collaboration to gain traction. getAbstract recommends this lecture to those interested in new investment opportunities, good deeds, research and development, or all three.
In this summary, you will learn
- What factors slow or stall drug development,
- How a new approach makes it easier to fund research, and
- Why collaboration between individual investors and the drug industry can save lives.
About the Speaker
Finance expert Roger Stein is a senior lecturer at MIT's Sloan School of Management.
Comment on this summary
Customers who read this summary also read
Financial Times, 2017
Vincent DeVita and Elizabeth DeVita-Raeburn